DFTX
🟢 Definium Therapeutics is trading 4.03% up today after positive Phase 3 Voyage results
Definium Therapeutics is trading 4.03% up now at $44.52 after positive Phase 3 Voyage results announced August 12, 2026.
- The DT120 ODT study met its primary...
